Pancreatitis crónica: Una revisión de sus aspectos más relevantes
DOI:
https://doi.org/10.52787/agl.v53i2.328Palabras clave:
Pancreatitis crónica, dolor pancreático, insuficiencia pancreática exocrinaResumen
La pancreatitis crónica es una entidad dinámica y progresiva. Las interacciones entre los distintos factores de riesgo definen las manifestaciones clínicas y el perfil de complicaciones de cada paciente individual. La evaluación y el manejo del dolor y de las insuficiencias funcionales son los pilares del plan de cuidados de los pacientes con esta condición. La educación para la corrección de los factores de riesgo modificables es fundamental para impactar positivamente en la progresión de la enfermedad.
Citas
-1. Whitcomb DC, FrulloniL, Garg P, et al. Chronic pancreatitis: An international draft consensus proposal for a new mechanistic definition. Pancreatology. 2016;16:218-24.
-2. Gardner TB, Adler DG, Forsmark CE, et al. ACG Clinical Guideline: Chronic Pancreatitis. Am J Gastroenterol. 2020;115(3):322-39.
-3. Whitcomb DC, North American Pancreatitis Study Group. Pancreatitis: TIGAR-O Version 2 Risk/Etiology Checklist With Topic Reviews, Updates, and Use Primers. Clin Transl Gastroenterol. 2019;;10(6):e00027.
-4. Schneider A, Löhr JM, Singer MV. The M-ANNHEIM classification of chronic pancreatitis: introduction of a unifying classification system based on a review of previous classifications of the disease. J Gastroenterol. 2007;42:101-19.
-5. Kumar S, Ooi CY, Werlin S, et al. Risk Factors Associated with Pediatric Acute Recurrent and Chronic Pancreatitis: Lessons from INSPPIRE. JAMA Pediatr. 2016;170(6):562-9.
-6. Hegyi P, Párniczky A, Lerch MM, et al. International Consensus Guidelines for Risk Factors in Chronic Pancreatitis. Recommendations from the working group for the international consensus guidelines for chronic pancreatitis in collaboration with the International Association of Pancreatology, the American Pancreatic Association, the Japan Pancreas Society, and European Pancreatic Club. Pancreatology. 2020;20:579-85.
-7. Irving HM, Samokhvalov AV, Rehm J. Alcohol as a risk factor for pancreatitis. A systematic review and meta-analysis. JOP. 2009;10(4):387-92.
-8. Ye X, Lu G, Huai J, et al. Impact of smoking on the risk of pancreatitis: a systematic review and meta-analysis. PLoS One. 2015;10(4):e0124075.
-9. Luaces-Regueira, Iglesias-García, Lindkvist, et al. Smoking as a risk factor for complications in chronic pancreatitis. Pancreas. 2014;43(2):275-80.
-10. Olesen SS, Nøjgaard C, Poulsen JL. Chronic Pancreatitis Is Characterized by Distinct Complication Clusters That Associate with Etiological Risk Factors. Am J Gastroenterol. 2019; 114(4):656-64.
-11. Anderson MA, Akshintala V, Albers KM, et al. Mechanism, assessment and management of pain in chronic pancreatitis: Recommendations of a multidisciplinary study group. Pancreatology. 2016;16(1):83-94.
-12. Drewes AM, Bouwense SAW, Campbell CM, et al. Guidelines for the understanding and management of pain in chronic pancreatitis. Pancreatology. 2017;17(5):720-31.
-13. Kitano M, Gress TG, Garg PK, et al. International consensus guidelines on interventional endoscopy in chronic pancreatitis. Recommendations from the working group for the international consensus guidelines for chronic pancreatitis in collaboration with the International Association of Pancreatology, the American Pancreatic Association, the Japan Pancreas Society, and European Pancreatic Club. Pancreatology. 2020;20:1045-55.
-14. Drewes AM, Kempeneers MA, Andersen DK, et al. Controversies on the endoscopic and surgical management of pain in patients with chronic pancreatitis: pros and cons! Gut. 2019;68(8):1343-51.
-15. Kempeneers MA, Issa Y, Ali UA, et al. for the Working group for the International (IAP - APA - JPS - EPC) Consensus Guidelines for Chronic Pancreatitis. International consensus guidelines for surgery and the timing of intervention in chronic pancreatitis. Pancreatology., 2020;20(2,03):149-57.
-16. Basso S, Canicoba M, Capitanich P, et al. para el Club del Páncreas de la República Argentina. I Consenso argentino de diagnóstico y tratamiento de la insuficiencia pancreática exocrina. Acta Gastroenterol Latinoam. 2018;48(3):213-25.
-17. DomÍnguez-Muñoz JE, Drewes AM, Lindkvist B, et al. on behalf of the HaPanEU/UEG Working Group. Recommendations from the United European Gastroenterology evidence-based guidelines for the diagnosis and therapy of chronic pancreatitis. Pancreatology. 2018;18:847-54.
-18. Domínguez-Muñoz JE, Hardt PD, Lerch MM, et al. Potential for Screening for Pancreatic Exocrine Insufficiency Using the Fecal Elastase-1 Test. Dig Dis Sci. 2017;62:1119-30.
-19. Lindkvist B, Phillips ME, Domínguez-Muñoz JE. Clinical, anthropometric and laboratory nutritional markers of pancreatic exocrine insufficiency: Prevalence and diagnostic use. Pancreatology. 2015;15:589-97.
-20. Domínguez-Muñoz JE, MD, PhD, Phillips M. Nutritional Therapy in Chronic Pancreatitis. Gastroenterol Clin North Am. 2018;47(1):95-106.
-21. Löhr M, Domínguez-Muñoz JE, Rosendahl J, et al.; HaPanEU/UEG Working Group. United European Gastroenterology evidence based guidelines for the diagnosis and therapy of chronic pancreatitis (HaPanEU). United European Gastroenterology Journal. 2017;0(0):1-47.
-22. Phillips ME,e Hopper AD, Leeds JS, et al. Consensus for the management of pancreatic exocrine insufficiency: UK practical guidelines. BMJ Open Gastro. 2021;8:e000643.
-23. Ní Chonchubhair HM, Bashir Y, Dobson M, et al. The prevalence of small intestinal bacterial overgrowth in non-surgical patients with chronic pancreatitis and pancreatic exocrine insufficiency (PEI). Pancreatology. 2018;18(4):379-85.
-24. Domínguez-Muñoz JE. Management of pancreatic exocrine insufficiency. Curr Opin Gastroenterol. 2019;35:455-59.
-25. Stigliano S, Waldthaler A, Martínez-Moneo E, et al. Vitamins D and K as Factors Associated with Osteopathy in Chronic Pancreatitis: A Prospective Multicentre Study (P-BONE Study). Clinical and Translational Gastroenterology. 2018;9:197.
-26. Hart PA, Yadav D, Li L, et al. on behalf of the Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer (CPDPC). High Prevalence of Osteopathy in Chronic Pancreatitis: A Cross-sectional Analysis From the PROCEED Study. Clinical Gastroenterology and Hepatology. 2022;20:2005-13.
-27. Estrup Olesen A, Brokjaer A, Wendelboe Fisher I, et al. Pharmacological challenges in chronic pancreatitis. World J Gastroenterol. 2013;19(42):7302-7.
-28. Beyer G, Habtezion A, Werner J, et al. Chronic pancreatitis. Lancet. 2020;396:499-512.
-29. Gandhi S, De la Fuente J, Murad MH, et al. Chronic Pancreatitis a Risk Factor for Pancreatic Cancer, and Incidence Increases with Duration of Disease: A Systematic Review and Meta-analysis. Clinical and Translational Gastroenterology. 2022;13:e00463.
-30. Greenhalf W, Lévy P, Gress T, et al. for the Working group for the International (IAP e APA e JPS e EPC) Consensus Guidelines for Chronic Pancreatitis. International consensus guidelines on surveillance for pancreatic cancer in chronic pancreatitis. Recommendations from the working group for the international consensus guidelines for chronic pancreatitis in collaboration with the International Association of Pancreatology, the American Pancreatic Association, the Japan Pancreas Society, and European Pancreatic Club. Pancreatology. 2020;20(5):910-8.
-31. Singh VK, Yadav D, Garg PK. Diagnosis and Management of Chronic Pancreatitis: A Review. JAMA. 2019 Dec 24;322(24):2422-2434.
Publicado
Cómo citar
Número
Sección
Licencia
Derechos de autor 2023 Analía Verónica Pasqua
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-CompartirIgual 4.0.
